MedTrace Logo

Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease

NCT02627872 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-03-28

No results posted yet for this study

Summary

Chronic Obstructive Pulmonary Disease (COPD) is an increasing global health problem, which primarily increases among the female population. The purpose of this study is to perform in-depth clinical and molecular characterizations of early stage COPD patients, as well as healthy never-smoker and at-risk smoking control populations to identify molecularly related subgroups patients, including gender-related sub-phenotypes of COPD.

Conditions

Sponsors & Collaborators

  • University of California, San Francisco

    collaborator OTHER

  • Göteborg University

    collaborator OTHER

  • University of Bergen

    collaborator OTHER

  • University of Oulu

    collaborator OTHER

  • Kyoto University

    collaborator OTHER

  • Swedish Heart Lung Foundation

    collaborator OTHER

  • The Swedish Research Council

    collaborator OTHER_GOV

  • Region Stockholm

    collaborator OTHER_GOV

  • Vinnova

    collaborator OTHER_GOV

  • Swedish Foundation for Strategic Research

    collaborator OTHER

  • European Union

    collaborator OTHER

  • Karolinska Institutet

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2021-12-31
Completion
2030-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02627872 on ClinicalTrials.gov